LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.25 | 84.90 | 2670 | 4539 | 0.5881 | 0.8234 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.25 | 84.90 | 3343 | 4539 | 0.7364 | 0.8962 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.25 | 84.90 | 2998 | 4539 | 0.6604 | 0.8605 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 45.25 | 84.90 | 4523 | 4539 | 0.9963 | 0.9987 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 46.95 | 84.90 | 2616 | 4952 | 0.5282 | 0.7938 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 46.95 | 84.90 | 3495 | 4952 | 0.7057 | 0.8846 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 46.95 | 84.90 | 2589 | 4952 | 0.5228 | 0.7907 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 46.95 | 84.90 | 4798 | 4952 | 0.9688 | 0.9892 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 48.65 | 84.90 | 2730 | 5328 | 0.5123 | 0.7881 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 48.65 | 84.90 | 3708 | 5328 | 0.6958 | 0.8822 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 48.65 | 84.90 | 1716 | 5328 | 0.3220 | 0.6543 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 48.65 | 84.90 | 5047 | 5328 | 0.9471 | 0.9819 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.36 | 84.90 | 2700 | 5651 | 0.4778 | 0.7704 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.36 | 84.90 | 3837 | 5651 | 0.6790 | 0.8762 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.36 | 84.90 | 1419 | 5651 | 0.2511 | 0.5920 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.36 | 84.90 | 5237 | 5651 | 0.9267 | 0.9750 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.06 | 84.90 | 2707 | 5990 | 0.4519 | 0.7573 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.06 | 84.90 | 4021 | 5990 | 0.6712 | 0.8743 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.06 | 84.90 | 1414 | 5990 | 0.2360 | 0.5810 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.06 | 84.90 | 5469 | 5990 | 0.9129 | 0.9705 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.77 | 84.90 | 2796 | 6252 | 0.4472 | 0.7566 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.77 | 84.90 | 4182 | 6252 | 0.6688 | 0.8744 | MN20160318_Q02 | E06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.77 | 84.90 | 1128 | 6252 | 0.1804 | 0.5175 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.77 | 84.90 | 5579 | 6252 | 0.8923 | 0.9636 | MN20160318_Q02 | I11 |
MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.48 | 84.90 | 2472 | 6567 | 0.3764 | 0.7115 | MN20160318_Q02 | E06 |